DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP

glenmark pharmaceuticals canada inc.🇨🇦 Health Canada

Approval Id: be9b88ef1c3d31cc
Drug Approval Canada Name: DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP
Product Name: DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS USP
Status: Marketed
Status Date: 2021-09-07
Original Market Date: 2021-09-07
Din: 02462060
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 68:12.00
Atc Original: G03AA12 DROSPIRENONE AND ESTROGEN
Atc Name: g 03 aa 12
Aig Number: 0250430002
Company Name: glenmark pharmaceuticals canada inc.
Company Address: 1600 Steeles Ave. W., Suite 407, Concord, Ontario, Canada, L4K 4M2

DROSPIRENONE

3 MG

ETHINYL ESTRADIOL

0.02 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

be9b88ef1c3d31cc

Type

Standard